NCT03423238

Brief Summary

Although coronary heart disease (CHD) treatment guidelines recognize obesity as a major modifiable risk factor,2 nearly half of all CHD patients are obese and the current standard of care fails to implement evidence-based obesity treatment for this high-risk population. Multiple lines of evidence suggest that weight loss improves outcomes in CHD patients. The primary goal of this study is to determine the feasibility of adding a 6-month behavioral weight loss intervention to exercise-based cardiac rehabilitation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 6, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

March 21, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2020

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

November 23, 2021

Completed
Last Updated

November 23, 2021

Status Verified

September 1, 2021

Enrollment Period

2.1 years

First QC Date

January 26, 2018

Results QC Date

July 29, 2021

Last Update Submit

October 29, 2021

Conditions

Keywords

CardiacRehabDietExerciseObese

Outcome Measures

Primary Outcomes (3)

  • Feasibility - Number of Enrolled Participants

    Total number of participants who met all inclusion/exclusion criteria and were enrolled in the study

    18 months

  • Compliance - Percentage of Sessions Attended

    The percentage of exercise/counseling sessions attended (calculated as the number of sessions attended divided by the number of sessions prescribed multiplied by 100)

    6 months

  • Retention - Percentage of Participants Who Returned for Follow-up Testing

    The number of participants who returned for the 6-month follow-up visit divided by the total number of randomized participants multiplied by 100

    6 months

Secondary Outcomes (28)

  • Body Weight

    Baseline

  • Body Weight

    Months 3 and 6

  • 6 Minute Walk (6MW) Test

    Baseline

  • 6 Minute Walk (6MW) Test

    Months 3 and 6

  • Grip Strength

    Baseline

  • +23 more secondary outcomes

Study Arms (2)

Rehab Only

ACTIVE COMPARATOR

Patients will be randomized to Rehab only using a randomization scheme with blocking stratified by sex and obesity severity (BMI\<30 vs. BMI≥30 kg/m2). All participants will undergo standard exercise-based cardiac rehabilitation, which includes meeting with dietitian, exercise, health education, and exercise compliance.

Other: ExerciseBehavioral: Health EducationOther: Exercise ComplianceOther: Dietary Counseling

Rehab+Weight Loss (WL)

EXPERIMENTAL

Patients will be randomized to Rehab+WL using a randomization scheme with blocking stratified by sex and obesity severity (BMI\<30 vs. BMI≥30 kg/m2). All participants will undergo standard exercise-based cardiac rehabilitation in addition to a weight-loss intervention, which includes meeting with dietitian, exercise, health education, and exercise compliance, calorie-restricted diet, behavioral modification, and weight-loss compliance.

Other: ExerciseBehavioral: Health EducationOther: Exercise ComplianceDietary Supplement: Calorie-Restricted DietBehavioral: Behavioral ModificationOther: Weight-Loss Compliance

Interventions

Each exercise session lasts for 60 to 90 minutes and consists of 5-10 minutes of warm-up and cool-down activity; up to 30 minutes of aerobic exercise using a variety of modalities (e.g., walking laps on a track, cycle ergometry, treadmills, stair climbers); and 15-20 minutes of upper and lower body resistance exercises using Thera-Bands. An exercise physiologist creates an individualized plan

Rehab OnlyRehab+Weight Loss (WL)

Group education classes conducted by an exercise physiologist and/or dietitian are designed to provide support and general information on healthy lifestyle behaviors. Topics include risk factor control, diabetes, hypertension, lipids, medications, aerobic exercise, strength training and flexibility, weight control, reading food nutrition labels, eating out, holiday eating, intimacy, stress, relaxation, cardiac symptoms, and cardiac interventions.

Rehab OnlyRehab+Weight Loss (WL)

Multiple behavioral management strategies to create a positive exercise environment and promote adherence and retention will be utilized. These include promptly contacting participants who miss a session, scheduling makeup sessions, and offering individual counseling sessions to discuss strategies to promote attendance and limit obstacles to participation.

Rehab OnlyRehab+Weight Loss (WL)
Calorie-Restricted DietDIETARY_SUPPLEMENT

Diet plans will provide a caloric deficit of 500 kcals per day. The lowest calorie level permitted will be 1,100 kcals for women and 1,200 kcals for men. The calorie distribution goal will be 15-20% from protein, \<30% from fat, and 45-60% from carbohydrates. Participants will consume 2 meal replacements per day (Premier Protein shakes and bars); provided by the study)), along with one meal composed of traditional foods (500-750 kcals, low in fat, high in vegetables), and 1-3 snacks as needed (e.g., cereal bar, fruit, or vegetable, providing 100-150 kcals each). For the meal, patients will follow a weekly menu plan and recipes provided by the study. The food plan will be tailored to individual preferences and energy needs.

Rehab+Weight Loss (WL)

During months 1-3, participants will attend weekly individual behavioral counseling sessions with the study registered dietitian (RD); individual sessions will be held twice per month during months 4-6. The sessions will focus on self-monitoring, portion control, mindful eating, coping with negative thoughts, eating at regular times, and stress management. The RD will review individual progress, solve problems, answer questions, and set weight loss goals.

Rehab+Weight Loss (WL)

Participants will be asked to record their food and beverage intake in daily logs which will be reviewed weekly by the RD to verify compliance to the diet. Body weight will be measured weekly to ensure that participants are losing weight at an appropriate rate. If a participant is not meeting weight loss goals, energy intake will be modified accordingly to produce the desired rate of weight loss.

Rehab+Weight Loss (WL)

Participants have one meeting with the Rehab dietitian upon starting.

Rehab Only

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • documented CHD defined as hospitalization for MI/heart attack coronary artery bypass grafting (CABG) or percutaneous coronary intervention (i.e., angioplasty, stent)
  • age = 40 and older
  • overweight or obese based on an elevated BMI (≥25 kg/m2)

You may not qualify if:

  • body weight \>450 lbs
  • congestive heart failure (ejection fraction \<35%)
  • advanced kidney disease (on dialysis, or dialysis anticipated within 6 months)
  • cognitive impairment (Montreal Cognitive Assessment \[MoCA\] score \<22)
  • major depression (Patient Health Questionnaire \[PHQ-9\] ≥20)
  • severe pulmonary disease (i.e., oxygen-dependent)
  • significant impairment from a prior stroke or other neurologic disease or injury
  • high risk for non-adherence (i.e., unwilling or unable to comply with study requirements)
  • current participation in physical therapy or another weight loss study
  • current or recent use of weight loss medications (e.g., orlistat)
  • prior weight loss procedure
  • drug/substance abuse or excessive alcohol (\> 14 drinks per week) within the past 6 months
  • pregnant or pre-menopausal women
  • peanut allergy
  • milk allergy/lactose intolerance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

ObesityWeight LossCoronary Artery DiseaseMotor Activity

Interventions

ExerciseCaloric RestrictionBehavior TherapyNutrition Assessment

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight ChangesCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaDiet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaPsychotherapyBehavioral Disciplines and ActivitiesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Results Point of Contact

Title
Tina Brinkley
Organization
Wake Forest School of Medicine

Study Officials

  • Tina Brinkley, PhD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All assessments will take place by study staff blinded to the participant's treatment assignment. To ensure that staff remain blinded, participants will be asked not to discuss their intervention with the assessor
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2018

First Posted

February 6, 2018

Study Start

March 21, 2018

Primary Completion

April 10, 2020

Study Completion

April 10, 2020

Last Updated

November 23, 2021

Results First Posted

November 23, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations